Minimizing Side Effects

When lung cancer is treated with conventional radiation, it is difficult to deliver a high enough radiation dose to control the cancer without also damaging the normal lungs, esophagus, heart and spinal cord.

Proton therapy can more effectively treat these tumors—particularly larger ones— while better protecting critical structures from radiation. As a result, protons can minimize side effects such as lung inflammation (pneumonitis) or scarring (fibrosis), difficulty swallowing, heart complications, hospitalizations, and other side effects that are commonly seen with conventional lung cancer treatment.

Lung and Thoracic Cancers We Treat Include
  • Non-small cell lung cancer (NSCLC)
  • Small cell lung cancer (SCLC)
  • Malignant mesothelioma
  • Thymomas and thymic carcinomas
  • Cardiac tumors
  • Thoracic sarcomas
  • Recurrent thoracic cancers

Lung and Thoracic Tumors Proton Therapy FAQs

Read our frequently asked questions about proton therapy for head and neck tumors.

Clinical Trials for Lung and Thoracic Cancers

Learn about the available clinical trials for lung and thoracic cancers at the New York Proton Center.

Not All Proton Therapy Is Created Equal

Many other proton centers use “volumetric” beams that deliver a fixed quantity of energy to the entire tumor. But the pencil beam scanning technology at the New York Proton Center delivers “intensity-modulated proton therapy,” or IMPT.

Widely considered the most advanced form of proton therapy, IMPT can target different parts of the tumor with different radiation dose levels based on the prescription and tumor’s exact location, while better protecting the surrounding normal tissues from irradiation. That’s particularly valuable when treating the most complicated tumors.

Latest Articles